Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneLinda T. Vahdat, Joanne L. Blum, Patricia E. Cole et al.|Journal of Clinical Oncology|2009Cited by 245
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R. Jack, Norman L. Foster, Frederik Barkhof et al.|Alzheimer s & Dementia|2011Cited by 220
Quality Improvement Guidelines for Percutaneous Management of the Thrombosed or Dysfunctional Dialysis AccessJohn E. Aruny, Curtis W. Bakal, Curtis A. Lewis et al.|Journal of Vascular and Interventional Radiology|1999Cited by 219
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and CapecitabineJavier Cortés, Mary Ann Allison, Linda T. Vahdat et al.|Journal of Clinical Oncology|2010Cited by 217
Quality improvement guidelines for central venous access.Curtis A. Lewis, Alain Drooz, Timothy E. Allen et al.|PubMed|2003Cited by 185